The New Ghostbuster: Elsevier Reviews Articles On Wyeth Drugs
This article was originally published in The Pink Sheet Daily
Executive Summary
Elsevier's investigation follows reports that Wyeth hired an outside company to write positive articles about its drugs; publisher also responds to Sen. Grassley letter.
You may also be interested in...
Academic Archive of Pharma Marketing Data On Hold Without Funding
A UCSF group wants its Internet site to be a go-to place for internal documents that reveal the marketing behavior of pharma companies. But it may be awhile before the site can resume posting data unearthed in litigation.
Academic Archive of Pharma Marketing Data On Hold Without Funding
A UCSF group wants its Internet site to be a go-to place for internal documents that reveal the marketing behavior of pharma companies. But it may be awhile before the site can resume posting data unearthed in litigation.
J&J Faces New Round Of Risperdal Suits With Ghostwriting Claims
Johnson & Johnson has been hit with another wave of Risperdal (risperidone) product liability suits. While previous suits have claimed the antipsychotic caused diabetes, the current batch alleges that the drug induced gynecomastia, or breast enlargement, in boys and young men